Harrinarine Madhosingh, MD
Infectious Disease · Celebration, FLNPI 1235214388
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $76,568 of the $77,188 with a category attached, or 99.2%. Axogen accounts for 99.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $25,347 and has fallen 99.9% since, to $27 in 2025. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $2339.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$77K
- Insmed, Inc.$171
- AbbVie$144
- Gilead$67
- Merck$50
- Johnson & Johnson$43
- plus $32 from 2 others
What the payments were for
- Consulting fees$76,56899%
- Food & beverage$5681%
- Education$520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 17 | $76,681 |
| Insmed, Inc. | 5 | $171 |
| AbbVie(2 entities) | 2 | $144 |
| Gilead | 3 | $67 |
| Merck | 2 | $50 |
| Johnson & Johnson | 2 | $43 |
| Med-el Corporation | 1 | $27 |
| Kerecis Limited | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$55,768
- AVYCAZ$125
- Arikayce$119
How this compares
$77,188 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 180 | $318,469 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 12 | $44,071 |
| ErtapenemErtapenem Sodium | 73 | $32,903 |
| Cefepime Hcl | 143 | $32,437 |
| TivicayDolutegravir Sodium | 11 | $21,961 |
| EvotazAtazanavir Sulfate/Cobicistat | 11 | $15,619 |
| Meropenem | 57 | $10,902 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 28 | $5,683 |
| CeftriaxoneCeftriaxone Sodium | 46 | $4,102 |
| Cefdinir | 176 | $2,107 |
| Doxycycline Hyclate | 233 | $1,572 |
| Levofloxacin | 182 | $1,560 |
| Cefazolin Sodium | 21 | $795 |
| Sodium Chloride0.9 % Sodium Chloride | 18 | $744 |
| Minocycline Hcl | 14 | $613 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Celebration
- Lennox ArchibaldGainesville$2.1M
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
- Charlotte-Paige RolleOrlando$619K
- Kenneth AlexanderOrlando$474K
- Douglas BrustMiami$359K
- Christopher CooperAltamonte Springs$278K
- Federico HinestrosaOrlando$276K
- Cynthia RiveraMiami Beach$265K
- Sally AlrabaaTampa$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.